-
[show abstract]
[hide abstract]
ABSTRACT: Melanin-concentrating hormone (MCH)1 receptors are widely expressed in limbic structures and cortex. Their inactivation is associated with anxiolytic and antidepressive properties but little information is available concerning cognition. This issue was addressed using the selective antagonists, SNAP-7941 and GW3430, in a social recognition paradigm in rats. The muscarinic blocker, scopolamine (1.25 mg/kg s.c.), reduced social recognition, an action dose-dependently blocked by SNAP-7941 and GW3430 (0.63-10.0 and 20.0-80.0 mg/kg i.p., respectively) which did not themselves display amnesic properties. Further, in a protocol where a spontaneous deficit was induced by a prolonged inter-session delay, SNAP-7941 and GW3430 dose-dependently enhanced social recognition. In dialysis studies, SNAP-7941 (0.63-40.0 mg/kg i.p.) and GW3430 (10.0-40.0 mg/kg i.p.) elevated extracellular levels of acetylcholine (ACh) in the frontal cortex (FCX) of freely moving rats. The SNAP-7941 effect was specific, as it did not increase levels of ACh in ventral and dorsal hippocampus: moreover, it did not modify levels of noradrenaline, dopamine, serotonin and glutamate in FCX. Active doses of SNAP-7941 and GW3430 corresponded to doses (2.5-40.0 and 10.0-80.0 mg/kg i.p., respectively) exerting anxiolytic properties in Vogel conflict and ultrasonic vocalization tests, and antidepressant actions in forced swim, isolation-induced aggression and marble-burying procedures. In contrast to SNAP-7941 and GW3430, the benzodiazepine, diazepam, decreased social recognition and dialysate levels of ACh, while the tricyclic, imipramine, reduced social recognition and failed to enhance cholinergic transmission. In conclusion, at anxiolytic and antidepressant doses, SNAP-7941 and GW3430 improve social recognition and elevate extracellular ACh levels in FCX. This profile differentiates MCH1 receptor antagonists from conventional anxiolytic and antidepressant agents.
The International Journal of Neuropsychopharmacology 06/2008; 11(8):1105-22. · 4.58 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Aggrecanase plays a major role in cartilage proteoglycan degradation in rheumatic diseases such as osteoarthritis and rheumatoid arthritis. The search of new inhibitors of aggrecanase activity necessitates a robust assays in order to be able to screen large numbers of compounds. We present in this paper an assay based on the cleavage of His-tagged aggrecan interglobular domain by N- and C- terminus truncated, active aggrecanase-1/ADAMTS-4, with formation of the aggrecanase-specific ARGSV neoepitope. This is detected by anti-ARGSV antibody, in turn recognized by a fluorescent anti-IgG. Furthermore, the formation of the reaction products was confirmed by high-pressure capillary electrophoresis. This assay allows the rapid screening of aggrecanase inhibitors in a 96-well plate format, allowing an immediate transposition to high-throughput scale up.
Matrix Biology 06/2006; 25(4):261-7. · 3.30 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A structure-activity study was performed by synthesis on N,N'-disubstitution of 3-aminobenzo[c] and [d]azepin-2-one 2 and 3 to afford potent and specific farnesyl transferase inhibitors with low nM enzymatic and cellular activities.
Bioorganic & Medicinal Chemistry Letters 03/2004; 14(3):767-71. · 2.55 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A rapid structure-activity study was performed by parallel liquid synthesis on N,N'-disubstitution of 3-amino azepin-2-one to afford potent and specific farnesyl transferase inhibitors with low nM enzymatic and cellular activities. The activities of the selected compounds were validated in vivo, and compounds 41a and 44a presented significant antitumour activity.
Bioorganic & Medicinal Chemistry 08/2003; 11(14):3193-204. · 2.92 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The principles of the combinatorial synthesis of large compound libraries are described. It is shown that these technologies can afford unprecedented numbers of chemical entities thus increasing the molecular diversity of the universe of organic compounds. Library design is considered in view of the generation of a maximized diversity for a given set of synthetic products. The advantages of solid phase organic chemistry are stressed and compared to the achievements of solution procedures for the production of large compound collections. The trend from the truly combinatorial synthesis of millions of biooligomers towards the parallel synthesis of individual small organics is stated and exemplified. Finally, an overview is given of the methods developed for the structural identification of the active component(s) in compound libraries and arrays, including iterative deconvolution via re-synthesis, positional scanning or structural analysis of the ligand on a single polymer bead. Strategies are suggested for both lead discovery and lead optimization.
Chemometrics and Intelligent Laboratory Systems.